In the UK, cancer genetic testing is primarily conducted through targeted panels that focus on specific cancer types or known genetic mutations associated with particular cancers, such as BRCA1 and BRCA2 mutations for breast and ovarian cancers [1]. The gene discussed is BRCA1; the disease is cancer.